Berapa harga Nabriva Therapeutics plc (NBRV)

Harga Nabriva Therapeutics plc (NBRV) adalah $0.63

Apa kapitalisasi pasar Nabriva Therapeutics plc (NBRV)

Kapitalisasi pasar Nabriva Therapeutics plc (NBRV) adalah $284.20K

Nabriva Therapeutics plc (NBRV) EPS

Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.

Tahun	EPS	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

EPS

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	EPS	Perbedaan EPS	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-	US
Argenx SE ARGX.US	$27.74	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$13.70	-	BE

Perusahaan

EPS

Perbedaan EPS

Negara